Filter By Category
Archives
Share on -
EDASALONEXENT
Generic Name: EDASALONEXENT
ABSTRACT -
Edasalonexent is an orally administered small molecule designed to inhibit NF-kappaB signaling and reduce inflammation and fibrosis in Duchenne muscular dystrophy development programs.
DOSAGE -
Investigational oral dosing only; follow the relevant trial protocol. It has not been assigned a general approved dosing regimen in this template.
SIDE EEFECTS -
- Diarrhea
- Vomiting or nausea
- Rash
- Abdominal discomfort
- Headache or fatigue
ALLERGIC REACTIONS -
These symptoms may indicate an allergic reaction and require medical attention.
- Rash, urticaria, angioedema, bronchospasm, or anaphylaxis
DRUG INTERACTIONS-
- Salicylate-related interactions should be considered until product-specific data are reviewed
- Anticoagulants or antiplatelets may increase bleeding concerns
- NSAIDs or corticosteroids may alter gastrointestinal risk
PREAUTONS–
- Assess gastrointestinal tolerance, bleeding risk, and liver function
- Use pediatric DMD trial safeguards where relevant
- Verify current development status before clinical use
WARNINGS –
- Investigational product; not a substitute for approved DMD therapies
- Potential salicylate-related toxicity should be considered
Share on -
. Developed by